Company intelligence / Profile preview

Acesso Biologics

Las Vegas, Nevada, United Statesacessobio.com ↗

Ownership: Private
Employees: ~8
Development stage: Commercial

Overview

Acesso Biologics develops and markets advanced biologic wound care products including amniotic membrane grafts and platelet-rich plasma therapies. Their amniotic grafts have shown effectiveness in treating chronic wounds such as diabetic foot ulcers in real-world case series. The company emphasizes quality manufacturing using the patented Excellion® process and compliance with FDA/Good Tissue Practices. They collect post-treatment data from providers to support clinical outcomes.

Therapeutic areas: OtherDermatology
Modalities: BiologicPlatelet-Rich Plasma therapyAllograft tissue products (amniotic membrane grafts)
Industry: Biotech

Drug pipeline

2 assets

Acesso DL

Unknown

1 more asset in the full pipeline.

Request access →

Partnerships

Engagement with Indian Nation Clinicssupports MAHA ("Make America Healthy Again")

Beyond the preview

Go deeper on Acesso Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acesso Biologics.

Explore the full profile